Literature DB >> 35420651

Association Between Social Determinants of Health and Retinopathy of Prematurity Outcomes.

Reem Karmouta1,2, Marie Altendahl1, Tahmineh Romero3, Tracy Piersante1, Seth Langston4, Monica Khitri2, Jacqueline Kading1, Irena Tsui2, Alison Chu1.   

Abstract

Importance: Previous studies suggest that race or ethnicity may be associated with risk for developing retinopathy of prematurity (ROP). Little is known about how socioeconomic factors mediate the relationship between race or ethnicity and ROP outcomes. Objective: To evaluate how socioeconomic factors, in the context of race and ethnicity, are associated with ROP outcomes. Design, Setting, and Participants: This retrospective cohort study used US Census Bureau income data and electronic medical records from neonatal intensive care units at 4 hospitals, UCLA Mattel Children's Hospital, UCLA Santa Monica Hospital, Cedars-Sinai Medical Center, and Harbor-UCLA Medical Center. Eligible participants included neonates born at a gestational age (GA) of 30 weeks or less, birth weight less than 1500 g, or a GA at birth greater than 30 weeks but with an unstable clinical course. Participants were screened for ROP between January 1, 2010, and December 31, 2020. Exposures: Race and ethnicity data, GA, demographic and clinical information, proxy household income, and health insurance status were collected as risk factors. Main Outcomes and Measures: Diagnosis and severity of ROP were the main study outcomes. Severity was determined according to a classification system developed by the Early Treatment for Retinopathy of Prematurity Cooperative Group.
Results: In a crude model, Hispanic neonates were more likely to be diagnosed with ROP (OR, 1.70; 95% CI, 1.20-2.42) and had more severe ROP (OR, 2.24; 95% CI, 1.21-4.15) compared with non-Hispanic White neonates; these associations were no longer found when adjusting for GA and socioeconomic factors (OR, 1.12; 95% CI, 0.68-1.82, and OR, 1.67; 95% CI, 0.80-3.52, for ROP diagnosis and severity, respectively). In a fully adjusted model, lower GA was the primary predictor of ROP incidence (OR, 0.52; 95% CI, 0.48-0.57; P < .001), and higher median household income was associated with higher GA (OR, 0.26; 95% CI, 0.09-0.43; P = .002). Conclusions and Relevance: In this cohort study, GA was the primary driver of disparities in ROP outcomes in a heterogeneous population of neonates in Los Angeles, California. When examined in the context of socioeconomic factors, GA did not differ between racial and ethnic groups. Studies of disparities associated with race and ethnicity should consider these constructs in conjunction with other sociodemographic factors and social determinants of health.

Entities:  

Mesh:

Year:  2022        PMID: 35420651      PMCID: PMC9011172          DOI: 10.1001/jamaophthalmol.2022.0667

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   8.253


  14 in total

1.  Retinopathy of prematurity in the United States.

Authors:  E M Lad; T C Nguyen; J M Morton; D M Moshfeghi
Journal:  Br J Ophthalmol       Date:  2008-03       Impact factor: 4.638

2.  Retinopathy of Prematurity.

Authors:  Alice L Bashinsky
Journal:  N C Med J       Date:  2017 Mar-Apr

Review 3.  Screening examination of premature infants for retinopathy of prematurity.

Authors:  Walter M Fierson
Journal:  Pediatrics       Date:  2012-12-31       Impact factor: 7.124

4.  Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity.

Authors:  Shahid M Husain; Ajay K Sinha; Catey Bunce; Puneet Arora; Wilson Lopez; Kwok S Mun; M Ashwin Reddy; Gillian G W Adams
Journal:  J Pediatr       Date:  2013-01-23       Impact factor: 4.406

5.  Evaluating area-based socioeconomic status indicators for monitoring disparities within health care systems: results from a primary care network.

Authors:  Seth A Berkowitz; Carine Y Traore; Daniel E Singer; Steven J Atlas
Journal:  Health Serv Res       Date:  2014-09-15       Impact factor: 3.402

6.  Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.

Authors:  R A Saunders; M L Donahue; L M Christmann; A V Pakalnis; B Tung; R J Hardy; D L Phelps
Journal:  Arch Ophthalmol       Date:  1997-05

7.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  2003-12

8.  Visual and Hearing Impairments After Preterm Birth.

Authors:  Mikko Hirvonen; Riitta Ojala; Päivi Korhonen; Paula Haataja; Kai Eriksson; Mika Gissler; Tiina Luukkaala; Outi Tammela
Journal:  Pediatrics       Date:  2018-07-17       Impact factor: 7.124

9.  Achieved oxygen saturations and retinopathy of prematurity in extreme preterms.

Authors:  Marie G Gantz; Waldemar A Carlo; Neil N Finer; Wade Rich; Roger G Faix; Bradley A Yoder; Michele C Walsh; Nancy S Newman; Abbott Laptook; Kurt Schibler; Abhik Das; Rosemary D Higgins
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2019-06-22       Impact factor: 5.747

10.  The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.

Authors:  Erik A Jensen; Kevin Dysart; Marie G Gantz; Scott McDonald; Nicolas A Bamat; Martin Keszler; Haresh Kirpalani; Matthew M Laughon; Brenda B Poindexter; Andrea F Duncan; Bradley A Yoder; Eric C Eichenwald; Sara B DeMauro
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

View more
  1 in total

1.  Effect of foveal morphology on visual acuity in 4-6-year-old children with retinopathy of prematurity: a J-CREST study.

Authors:  Tomo Nishi; Tetsuo Ueda; Yuutaro Mizusawa; Kayo Shinomiya; Yoshinori Mitamura; Naoki Kimura; Fumi Gomi; Akiko Miki; Makoto Nakamura; Takamasa Kinoshita; Shumpei Obata; Masahito Ohji; Takuya Tsuji; Shigeo Yoshida; Nahoko Ogata
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.